Brian Nowosielski

Check out this recap of articles published on our sister sites during the past week.

A cohort study was conducted to address the association between patients with cannabis-related disorders and their risk of developing head and neck cancer.

Researchers addressed the difference between prescribing guselkumab doses every 16 weeks and every 8 weeks for super responder patients with moderate to severe psoriasis.

Researchers conducted a systematic review of literature exploring the misuse of opioid prescriptions for patients with chronic non-cancer pain.

Researchers tested various text-to-image generation platforms to better understand issues of representation within artificial intelligence.

See what’s trending in pharmacy with a preview of the Total Pharmacy August issue.

J.D. Power released a report detailing the change in mail-order and retail pharmacy trends from 2023 to 2024.

Check out this recap of articles published on our sister sites during the past week.

Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.

Researchers aimed to address the association of all-cause dementia risk and 3 separate chronicities of anxiety.

Catch up on important immunization news from the month of July.

Researchers aimed to address the change in trust individuals exhibited regarding US physicians and hospitals during the COVID-19 pandemic.

CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.

Researchers analyzed the prominence of opioid and methadone prescriptions for hospitalized newborns with substantial morbidities.

Erin Albert, Vice President of Pharmacy Relations and Chief Privacy Officer at Mark Cuban Cost Plus Drug Company, PBC, discussed the changing landscape regarding prescription drug pricing.

Jon Minkin, Enterprise Account Executive at NimbleRx and pharmacy technology expert, discussed how his company can help independent pharmacies unlock revenue opportunities.

Check out this recap of articles published on our sister sites during the past week.

Researchers aimed to address the associations between prenatal cannabis use and maternal health outcomes over a 9-year period.

The American College of Allergy, Asthma, and Immunology (ACAAI) recently released its 5 tips to help children and their parents stay educated on asthma peak month.

In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.

A survey conducted by Surescripts, a health care solutions company, explored the attitudes of pharmacists and prescribers towards ongoing issues and challenges currently facing the industry.

Industry experts explored the increase in US prescription drug spending and how state spending targets come into play regarding patients’ rising out-of-pocket costs.

Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.

Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), sat down with Drug Topics to discuss Pharmacy Benefit Managers.

Check out this recap of articles published on our sister sites during the past week.

Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.

Emporos announced a strategic partnership with InterLink AI to help pharmacists streamline tasks and fill more prescriptions.

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

The CDC issued a report on the state of the avian influenza, or bird flu, at the end of last week.

As the end of the DSCSA stabilization period approaches, Scott Mooney, vice president of distribution operations at McKesson, discussed what pharmacists should consider to be prepared.